Given the gradual increase of positives to SARS-CoV-2 since the first week of this year and forecasts of a new wave in the world of cases at risk of being infected with the Omicron variant of the coronavirus, the province's health system introduced variations to the established protocol in the diagnosis and clinical management of patients confirmed with COVID-19, as well as suspects and first-order contacts of the positives.
Read more COVID-19: New protocol measures for diagnosis and treatment
Cuba will assume today for the first time the pro tempore presidency of the G77+China to promote the objectives of the 2030 Agenda and foster international solidarity and cooperation in the post-pandemic context.
Health workers, students of Medical Sciences and other risk groups, including those from the Tourism sector, the Ministry of the Interior and Transportation in the province of Holguín began to receive single anti-COVID booster doses of Abdala, with the aim of maintaining immunity against the lethal disease.
Read more Vaccination with booster doses begins in Holguín
The inclusion of patients in the NeuroEpo clinical trial (CT) in mild and moderate Alzheimer's will begin in Holguín next September, after a period of organization and evaluation in the territory, where the study will be assumed by the Provincial Group of CT and will include a multidisciplinary team of neurologists, psychiatrists, neuropsychologists, among other specialties.
Read more Holguín prepares to start NeuroEpo clinical trialMore Articles
Page 317 of 497